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mortality. The ﬁve-year survival rate of patients with N2 disease (n=26) 
was 13% and those with N0-1 (n=23) was 29% (p> 0,05).
Conclusions: Radical resection of lung cancer with left atrial is fea-
sible, and it could lead to permanent cure in carefully selected patients.
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Analysis about clinicopathologic characteristics of lung 
adenosquamous carcinoma
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Objective: In order to improve the efﬁcacy of treatment of lung 
adenosquamous carcinoma, we retrospectively reviewed the clinico-
pathologic characteristics of 63 cases who were surgically treated in 
our hospital. 
Methods: From Jan.1994 to Dec.2004, 63 patients of primary lung 
adenosquamous carcinoma were treated surgically. Their clinical and 
pathological records were reviewed. 
Results: Lung adenosquamous carcinoma comprised 11.5% of total 
patients surgically treated for the primary lung cancer during the 
same period. 12 cases(19.0%) were diagnosed before operation. 49 
cases(77.8%) had lymph nodes metastasis(LNM). The degree of LNM 
was 43.9%. 
Conclusions: Lung adenosquamous carcinoma is a more virulent 
tumor, which exhibited highly aggressive biological behavior and 
higher rate of lymph node metastasis. Its prognosis is worse than other 
NSCLC. To obtain a better effect, multi-modality therapy should be 
used with surgical treatment. 
Pathology
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Thoracocardiovascular surgery and pathology of 255 patients with 
cardiac tumors: 30 years of experience in the Philippine Heart 
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Background: Diseases of the Heart, Vascular, Respiratory System and 
malignant neoplasm remains to be the leading cause of mortality in the 
Philippines. Thoracic surgeons and Pathologists are often faced with di-
agnostic and therapeutic dilemmas when presented with cardiac tumors. 
Most often physicians are caught unaware and the decision to undergo 
surgery is almost always necessary before the patient deteriorates.
Methods: To describe the incidence primary cardiac tumors from 1976 
to 2006 at the Philippine Heart Center based on age, gender and man-
ner of presentation, frequency, localization, implantation site, associ-
ated ﬁndings and histopathologic diagnosis and to review cardiac tumor 
registry, patient records and glass slides. On selected cases, additional 
immunohistochemical studies were done from parafﬁn block tissues. 
We used descriptive statistics, and quantitative variables are expressed 
as mean, range and standard deviation whereas qualitative variables are 
expressed as proportions.
Results: 255 patients underwent thoracocardiovascular surgery (me-
dian sternotomy with cardiopulmonary bypass) with primary cardiac 
tumors established clinically and echocardiographically with histo-
pathologic correlation. All cases were derived from autopsy material 
and / or surgically resected specimen. Primary cardiac tumors were 
benign in 91.8 % and malignant in 8.2 %. Of the total 255 cases, 89% 
were adults, and 11% were pediatric cases. Generally the most common 
tumor is myxoma, (86%) followed by metastatic tumors (1.6%). Main 
affected gender was females in 60% of cases. Average age ranges from 
29 days to 82 years with a mean age of 41 years. The most common 
initial presentation was dyspnea and chest pain. Most patients were in 
sinus rhythm, and the best diagnostic tool was 2D echocardiography. In 
adults, myxomas were the most common tumor whereas rhabdomyoma 
occurred most frequently in the pediatric age group. Myxomas were 
mostly located in the left atrial septum, and in decreasing frequencies, 
the left atrial free wall, right atrial free wall, right ventricle and biatrial 
and more were pedunculated and attached to the interventricular 
septum. Tumor size ranged from 2.5 to 12.5 cms in greatest diameter. 
Metastatic tumors were from the lungs and kidney, which may also 
affect the heart by tumor progression via the inferior vena caval vein. 
Sarcomas were most common malignant tumor in adults. Rhabdomyo-
sarcoma, angiosarcoma, myxosarcoma, leiomyosarcoma and malignant 
ﬁbrous histiocytomas were reported.
Conclusion: The series of neoplasm presented varies in clinical pre-
sentation and is speciﬁc for every tumor. Its symptoms depend on the 
location of tumor, its extent and severity. Although most cardiac tumors 
are benign, they can be lethal despite their histology. The advent of 
cardiac imaging, and cardiac surgery, modern immunohistochemical 
studies have aided in the prompt diagnosis of cardiac tumors. Since 
cardiovascular disease and cancer are both common, precise knowl-
edge is necessary. Cardiac tumors are unique and rare that requires the 
physician’s high degree of suspicion.
P1-159 Pathology Posters, Mon, Sept 3 
Pathology of rare benign vascular tumors of the thorax
Asuncion, Bernadette R.1 Gadingan, Donaldson M.2 Padua, Roberto D.2 
1 Philippine Society of Pathologists, Quezon City, Philippines 2 Philip-
pine Heart Center, Quezon City, Philippines 
Background: Vascular lesions of the thorax are extremely rare. 
Few literatures can be obtained and its origin is still a major ﬁeld of 
research. The occurrence of thoracic vascular lesions triggers specu-
lations that these lesions, if left untreated, may further enlarge and 
rupture.
Methods: To present a series of diagnosed cases of vascular lesions of 
the thorax, seen in the Philippine Heart Center in the last 10 years, such 
as
(1) Cardiac Hemangioma Obstructing The Right Ventricular Outﬂow 
Tract: A rare case of a 35-year-old female who presented with easy 
fatigability and exertional dyspnea. Imaging studies revealed a cardiac 
mass obstructing the right ventricular outﬂow tract. The diagnosis of 
vascular malformation consistent with cardiac hemangioma was con-
ﬁrmed on histopathologic examination. The postoperative course was 
uneventful.
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Cardiac hemangioma is one of the rare benign primary cardiac tumors 
with an incidence of 1% to 2%. To date, less than 15 cases of cardiac 
hemangioma causing RVOT obstruction have been reported.
(2) Posterior Mediastinal Vascular Malformation: A rare case of a 27-
year-old male with an incidental ﬁnding of a right lung mass on chest 
radiograph and was conﬁrmed as a posterior mediastinal mass on CT 
scan. The patient underwent thoracotomy to debulk the tumor, how-
ever, the procedure was aborted due to tremendous bleeding. The tissue 
samples submitted revealed an arteriovenous malformation and was 
conﬁrmed on special and immunohistochemical staining. The patient 
was then scheduled for angiogram and embolization.
Most tumors of the posterior mediastinum are neurogenic in origin. An 
arteriovenous malformation in the posterior mediastinum is a very rare 
neoplasm with only 2 reported cases. To the best of our knowledge, this 
seems to be the third reported case of posterior mediastinal arteriove-
nous malformation (AVM).
(3) Pulmonary Sclerosing Hemangioma: A rare case diagnosed by 
frozen section biopsy in a 41 year old asymptomatic female who pre-
sented with a solitary pulmonary nodule discovered on routine annual 
medical chest radiograph. Immunohistochemical stains such as Thyroid 
Transcription Factor I (TTFI), Epithelial Membrane Antigen (EMA) 
and Cytokeratin were done. 
Pulmonary Sclerosing Hemangiomas are rare, slowly growing benign 
neoplasms of uncertain histogenesis. 
Results: Vascular lesions are difﬁcult to diagnose for the inexperienced 
pathologist, clinician and thoracic surgeon. These lesions must be 
properly evaluated prior to any surgical procedure to prevent further 
complications such as bleeding. For pathologists, differentiating hem-
angiomas from other vascular tumors are difﬁcult because most often 
and commonly in these three presented cases, biopsy material sent to 
the laboratory is inadequate and not representative of the entire mass. 
With minimal surgical specimen, the pathologist was able to conﬁrm 
the benign nature of the lesion with immunohistochemical stains such 
as CD 31, S100, Factor VIII and elastic stain.
Conclusion: We have presented three thoracic vascular tumors to 
increase the awareness that although these tumors are rare and histo-
logically benign, they may be life-threatening. Its treatment requires 
careful judgment and multidisciplinary team approach with the thoracic 
surgeon, cardiologist, pulmonologist and pathologists as well. 
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Background: CD4+CD25+ Regulatory T cells (Tregs) have been 
shown to suppress host immune responses to a variety of cancers. 
Nuclear Foxp3 is currently the only speciﬁc marker for regulatory T 
cells. We describe the presence and pattern of Foxp3+ lymphocyte inﬁl-
tration in human non-small cell lung cancers, conﬁrming the presence 
of regulatory T cells with the hope of future immune targeted therapies.
Methods: Sixteen cases of formalin ﬁxed parafﬁn embedded lung 
tissue were selected from the pathology archives, [13 primary lung car-
cinomas (5 squamous cell carcinoma, 4 adenocarcinoma, 3 adenocar-
cinoma with bronchoalveolar features (BACF), and 1 bronchoalveolar 
carcinoma (BAC), 2 inﬂammatory (1 bronchiectasis and 1 interstitial 
ﬁbrosis) and 1 metastatic thyroid carcinoma]. Ages were 39-83 years, 
there were 10 women. The tissue was incubated with 1:50 dilution 
of puriﬁed anti-Foxp3 antigen (Biolegend). The amount of lymphoid 
stroma was measured as the percent of lymphoid tissue within 10 tumor 
high power ﬁelds (hpf- 20x).The percent of Foxp3 positive lympho-
cytes within each lymphoid aggregate was measured as percent positive 
per aggregate (40x). These were multiplied to give a Treg expression 
index (Foxp3 expression/aggregate)(number of aggregates).
Results: Squamous carcinoma had the least amount of lymphoid tissue 
(4.2%) and BAC/BACF had the greatest (6%). The greatest number of 
Tregs per hpf lymphoid tissue was in the metastasis (40/ﬁeld) and least 
in inﬂammation (17.5/ﬁeld). The highest Treg index was in the case of 
pulmonary metastasis (200). Of the primary lung tumors, adenocarcino-
ma (181), BAC (162) and BACF (146) were the highest. Inﬂammation 
(96.2) and squamous carcinoma (83.2) were at the low end. No trend 
was identiﬁed regarding location of lymph tissue at the tumor interface 
or within the tumor. 
Conclusions: All lymphoid aggregates showed a sprinkling of Foxp3 
positive nuclei suggesting that Tregs are present in all inducible lym-
phoid tissue, with variations in tumor type and total lymphoid quantity. 
Tumors that induced a greater amount of lymphoid stroma tended to 
have the greatest Foxp3 index. We did not ﬁnd any case without at least 
scant Treg presence. Future immune directed therapeutic intervention 
may be possible after understanding the presence and pattern of these 
cells in non-small cell lung cancers.
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Nuclear and cytoplasmic cellular distribution of survivin as 
survival predictor in resected non-small-cell lung cancer
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Background: Survivin is a member of the inhibitors of apoptosis (IAP) 
gene family that acts through pathways different from those involving 
the bcl-2 family. Largely undetectable in normal adult tissues, survivin 
is deregulated in most human cancers including non-small-cell lung 
cancer (NSCLC) and may represent a tumor marker with prognostic 
and therapeutic implications. Aim of our study was to determine the 
prognostic role of survivin as an apoptosis-related biomarker in a series 
of early-stage NSCLC patients.
Methods: A retrospective series of resected NSCLC patients was 
retrieved from the ﬁles of the Regina Elena National Cancer Insti-
tute. Survivin was detected by immonohistochemistry (IHC) using a 
polyclonal antibody. Survivin displayed two kinds of immunoreactiv-
ity: a diffuse cytoplasmic staining and a distinct nuclear staining. A 
score-scale to distinguish positive (score 1-2) versus negative (score 0) 
pattern was applied. Clinical and biological (nuclear and cytoplasmic 
survinin staining) covariables were screened for a prognostic rela-
tionship with overall (OS) and progression free-survival (PFS) into a 
univariate and multivariate analysis. 
Results: Data referring to 116 NSCLC patients who underwent surgery 
for stage I-IIIA NSCLC were collected. Multivariate analyses identiﬁed 
tumor size, nodal status and nuclear, but not cytoplasmic, expression 
of survivin as signiﬁcant independent predictors of OS, with an hazard 
